Skip to content

SXTPW 60 DEGREES PHARMACEUTICALS I

Follow

*W EXP 07/12/202 (warrant or right), issuer CIK 1946563

Filings received so far for Q3 2026: 5 13F filers report a position in SXTPW shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Walleye Capital LLCin group Walleye Capital LLC200,481$5.05K<0.01%013F-HRTimelineGroup
Clear Street Group Inc.in group Clear Street Group Inc.145,969$3.68K<0.01%013F-HRTimelineGroup
TORNO CAPITAL, LLC47,169$1.19K<0.01%013F-HRTimelineThe filing omitted confidential holdings, a later amendment may add them.
UBS Group AGin group UBS Group AG1,368$38<0.01%+72113F-HRTimelineGroup
Virtu Financial LLCin group Virtu Financial LLC11,552$00%new13F-HRTimelineGroupValue filed as zero, left out of ratios.